HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $7 Price Target

Benzinga · 10/16 18:39
HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $7 price target.